|
Search
Collections
Benchmarks
Upload document
Product
Dorzotimol eye drops
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Primary Open Angle Glaucoma of Both Eyes
Clinical trial
An Open-label, Randomized, Controlled, Comparative Efficacy and Safety Study of Dorzotimol Eye Drops, 20 mg/mL + 5 mg/mL (JGL dd, Croatia), vs. Cosopt® Eye Drops, 20 mg/mL + 5 mg/mL (Merck Sharp & Dohme, France) in Patients With POAG
Status: Completed
, Estimated PCD: 2018-09-17